Results from a clinical trial show a combination of two synthetic antibodies reduces deaths in hospitalized Covid-19 patients with no earlier immune response. . . . → Read More: Antibodies Help Some Hospitalized Covid-19 Patients
|
|||||
|
       
  |
Two biotechnology companies are designing therapies to deliver edited genes to treat Friedreich’s ataxia and amyotrophic lateral sclerosis, or ALS. . . . → Read More: Biotechs Partner on Crispr Therapies for Neuro Disorders 
Two U.S. government health agencies agreed to purchase some 1.7 million doses of a Covid-19 antiviral drug, once the drug receives clearance from FDA. . . . → Read More: U.S. to Buy Covid-19 Antiviral Drug in $1.2B Deal 
The Food and Drug Administration updated its emergency authorization for a dual-antibody Covid-19 therapy to allow for a lower and injectable dose. . . . → Read More: FDA Okays Lower Dose, Injected Covid-19 Antibodies 
Tests with lab mice show one dose of a lower cost Covid-19 vaccine given with a needle-free patch generates strong antibody and cellular immune responses. . . . → Read More: Low Cost Vaccine, Patch Device Produce Immune Responses 
The leaders of four international economic and health organizations call for a $50 billion investment to ensure faster vaccinations in all parts of the world. . . . → Read More: Trade, Finance, Health Groups Urge Vaccine Boost  Comments are closed  Finance, Joint ventures/collaborations  biomedical, Covid-19, debt, grant, health care, investment, pharmaceuticals 
Findings from the YouGov poll show the likelihood of children in the U.S. getting a Covid-19 vaccine depends largely on their parents’ vaccination status or plans. . . . → Read More: Infographic – U.S. Kids Vaccine Status Matches Parents Comments are closed New products behavioral science, biomedical, Covid-19, FDA, health care, pharmaceuticals, statistics 
Chemists at industry and academic labs created safer lipids for delivering messenger RNA vaccines, such as those protecting against Covid-19. . . . → Read More: Plant-Based Lipids Developed for mRNA Vaccines One comment - (Comments are closed) Joint ventures/collaborations, New products biomedical, biotechnology, chemistry, Covid-19, engineering, Europe, life sciences, manufacturing, nanotechnology, pharmaceuticals, physical sciences, university 
Moderna Inc. and South Korea signed agreements Saturday on joint research and manufacturing opportunities for vaccines against viruses in Korea. . . . → Read More: Moderna Expands Vaccine Research, Mfring in Asia 2 comments - (Comments are closed) Joint ventures/collaborations Asia, biomedical, biotechnology, Covid-19, genomics, Japan, Korea, life sciences, manufacturing, pharmaceuticals 
About two in three Americans are in favor of the U.S. sending Covid-19 vaccine doses to other countries where infections remain a problem. . . . → Read More: Infographic – Americans Support Sending Vaccines Abroad |
||||
|
Copyright © 2021 Technology News and Literature - All Rights Reserved Powered by WordPress & Atahualpa |
|||||